Posts by Sandra Ansanay-Alex
Swiss Cancer Research Foundation
The Swiss Cancer Research foundation is the largest funding organisation for cancer research in Switzerland. It supports research projects by independent scientists working at Swiss research institutions. As a scientist, you have the opportunity to submit an application for financial support for your research project. Application submission for cancer research grants is open twice…
Read MoreLara Chavaz from HUG Wins Swiss Childhood Cancer Research Award
The official award ceremony for the Swiss Childhood Cancer Research Prize took place in Bern on 18 June 2025, recognizing Lara Chavaz of the Geneva University Hospitals (HUG) for her outstanding contribution to pediatric oncology research. The CHF 35,000 prize honors innovative projects in basic research conducted at Swiss research institutes and hospitals. …
Read MoreTrends in Micro Nano
Trends in Micro Nano is organized on 9 September 2025 at HE-ARC, Neuchâtel Switzerland is at the forefront of global research in micro and nanotechnology, so register for the Trends in Micro Nano event organized by HE-ARC in Neuchâtel. Discover the latest innovations and trends presented by the leading Swiss players in the field.…
Read MoreForum HES-SO
The Forum HES-SO is taking place on 4 March 2026 at Beaulieu Lausanne Aimed at final-year students in the fields of Engineering and Architecture, Economics and Services, Social Work and Health, the HES-SO Forum is the ideal opportunity to prepare for entry into the professional world. This event also allows companies to meet new…
Read MoreUNIL Scientists Develop Innovative Method to Reverse Cellular Aging
A team of researchers at the University of Lausanne (UNIL) has unveiled a groundbreaking approach to combat cellular aging using a non-genetic, chemical-based method. Published in EMBO Molecular Medicine, their study demonstrates how a short treatment with a specific combination of small molecules can rejuvenate aged human cells and extend lifespan in microscopic worms, opening…
Read MoreComphya Closes Oversubscribed CHF 7.5 Million Series A Round
Comphya SA, a Vaud-based clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, announced the closing of an oversubscribed Series A financing round. Including the conversion of existing convertible loans, the round brings Comphya’s total equity raised to CHF 7.5 million (~USD 8.4 million). “We are…
Read MoreHilo by Aktiia Received FDA 510(k) Clearance for its Blood Pressure Monitor Wristband
The CSEM spinoff Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band. Thi wearable uses an optical sensor to collect data from one’s wrist. The Hilo by Aktiia wrist wearable is one of a kind as it collects one’s blood…
Read MoreVenture Leaders Medtech Presents the 2025 Cohort
Ten promising startups have been named to the Swiss National Medtech Team 2025 and will travel to Boston from 28 September to 3 October to pitch to investors, expand their network, and meet industry leaders. The Venture Leaders Medtech programme is organized by Venturelab, with the support of EPFL, ETH Zurich, Hansjörg Wyss, Helbling…
Read MoreThe Medtech Forum
The Medtech Forum 2026 is taking place from 13 to 15 May in Lisbon, Portugal The MedTech Forum is the largest health and medical technology industry conference in Europe and a key event since 2007. Industry leaders, leading innovators and investors to discuss the future opportunities in the medical technology sector. The 2025 programme…
Read MoreDeep Dive – How Gender Equity Drives Innovation
Join the Swiss Health Valley community for BioAlps’ next DEEP DIVE – How Gender Equity Drives Innovation – at Biopôle in Lausanne, on Thursday 28 August 2025 REGISTER NOW Programme 4.45 pm | Welcoming attendees (please join by 5.00 pm for a timely start) 5.00 pm | Welcome Magali Bischof, Secretary General, BioAlps…
Read More